β-Carbolines as potential anticancer agents.

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Beta-carbolines are indole alkaloids with a characteristic tricyclic pyrido[3,4-b]indole core structure.
• First isolated in 1841, their study has expanded significantly over centuries, leading to numerous derivatives.
• These compounds are abundant in nature and possess structural versatility.

Purpose of the Study:

• To review the synthesis, isolation, and anticancer activities of beta-carboline derivatives.
• To elucidate the mechanisms of action and structure-activity relationships (SAR) of these compounds.
• To highlight beta-carbolines as promising scaffolds for anticancer drug development.

Main Methods:

• Literature review focusing on isolation and synthesis of beta-carboline derivatives.
• Analysis of studies detailing anticancer activity against various targets.
• Examination of research on molecular interactions and SAR.

Main Results:

• Beta-carbolines interact with diverse anticancer targets, including DNA, enzymes (e.g., GPX4, topoisomerases), and proteins (e.g., tubulin, ABCG2/BRCP1).
• Their structural flexibility and reactivity enable broad-spectrum anticancer effects.
• Numerous beta-carboline derivatives have demonstrated significant cytotoxic and antiproliferative activities.

Conclusions:

• Beta-carboline derivatives are valuable lead compounds for anticancer drug discovery.
• Their multifaceted mechanisms of action warrant further investigation for therapeutic applications.
• Continued research into beta-carboline synthesis and SAR will likely yield novel anti-cancer agents.